Manoj Maniar
24Patents
11h-index
14Co-inventors
72Inventor score
Filing activity: Jun 4, 1990 → Jun 6, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5512055A | Anti-infective and anti-inflammatory releasing systems for medical devices | Human Necessities | 373 | Expired |
| US5227165A | Liposphere delivery systems for local anesthetics | Emerging Cross-Sectional Technologies | 133 | Expired |
| US5482927A | Controlled released microparticulate delivery system for proteins | Human Necessities | 127 | Expired |
| US5175235A | Branched polyanhydrides | Chemistry; Metallurgy | 59 | Expired |
| US5874469A | Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs | Human Necessities | 58 | Expired |
| US5886030A | Use of vitamin E tocopheryl derivatives in ophthalmic compositions | Human Necessities | 47 | Expired |
| US5240963A | Branched polyanhydrides | Human Necessities | 43 | Expired |
| US5179189A | Fatty acid terminated polyanhydrides | Human Necessities | 28 | Expired |
| US5919835A | Biodegradable polymer blends for drug delivery | Chemistry; Metallurgy | 19 | Expired |
| US5317079A | Fatty acid terminated polyanhydride | Human Necessities | 18 | Expired |
| US5705510A | Use of cabergoline and related ergoline derivatives for controlling intraocular pressure | Human Necessities | 14 | Expired |
| US5846525A | Protected biopolymers for oral administration and methods of using same | Human Necessities | 5 | Expired |
| US8476320B2 | Formulations for parenteral administration of amino-substituted (E)-2, 6-dialkoxystyryl 4-substituted benzylsulfones | Human Necessities | 4 | Active |
| US8063109B2 | Formulations for parenteral administration of (e)-2, 6-dialkoxystyryl 4-substituted benzylsulfones | Human Necessities | 4 | Active |
| US8889736B2 | Formulations for the treatment of pain | Human Necessities | 2 | Active |
| US9044427B2 | Compositions and methods for prevention and treatment of wounds | Human Necessities | 2 | Active |
| US10098862B1 | Formulations with enhanced stability and bioavailability for administration of (E)-2,6-dialkoxystyryl 4-substituted benzylsulfones | Human Necessities | 2 | Active |
| US10576047B2 | Formulations for the treatment of pain | Human Necessities | 2 | Active |
| US9060967B2 | Stable aqueous formulation of (E)-4-carboxystyryl-4-chlorobenzyl sulfone | Human Necessities | 1 | Active |
| US11382877B2 | Formulation of (E)-2,4,6-trimethoxystyryl-3-[(carboxymethyl)amino]-4-methoxybenzylsulphone with enhanced stability and bioavailability | Human Necessities | 1 | Active |
| US11583552B2 | Pharmaceutical formulation of arsenic trioxide | Human Necessities | 0 | Active |
| US9713597B2 | Stable aqueous formulation of (E)-4-carboxystyryl-4-chlorobenzyl sulfone | Human Necessities | 0 | Active |
| US12156856B2 | Formulation of (e)-2,4,6-trimethoxystyryl-3-[(carboxymethyl)amino]-4-methoxybenzylsulphone with enhanced stability and bioavailability | Human Necessities | 0 | Active |
| US10576050B2 | Methods and compositions for treatment of cancer | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.